Prospective Evaluation of the Cardiac Safety of HER2-targeted Therapies in Patients With HER2-positive Breast Cancer and Compromised Heart Function: The SAFE-HEaRt Study

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-019-05191-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

The Role of HER2 in Early Breast Cancer Metastasis and the Origins of Resistance to HER2-targeted Therapies

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2009English

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Safety and Pharmacokinetics of MM-302, a HER2-targeted Antibody–liposomal Doxorubicin Conjugate, in Patients With Advanced HER2-positive Breast Cancer: A Phase 1 Dose-Escalation Study

British Journal of Cancer
Cancer ResearchOncology
2018English

Efficacy and Safety of HER2-Targeted Agents for Breast Cancer With HER2-Overexpression: A Network Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Loss of HER2 Positivity After Anti-Her2 Chemotherapy in HER2-positive Gastric Cancer Patients: Results of the GASTric Cancer HER2 Reassessment Study 3 (GASTHER3)

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

A Changing Natural History of HER2-positive Breast Cancer Metastatic to the Brain in the Era of New, Targeted Therapies

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Targeted Therapeutic Options and Future Perspectives for HER2-positive Breast Cancer

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy